During the ' Lightning Round' of Mad Money Thursday night, Jim Cramer weighed in on Teva Pharmaceuticals (TEVA) : "No. We have Bristol-Myers Squibb (BMY) , why do we need Teva?" Let's revisit the charts of BMY to see if the bulls can push BMY to new all-time highs.
More from Investing
Value customers drive move away luxury pot products.
This shift in the character of the price action can't be shrugged off too quickly.
But that's exactly where we are right now, in this third day of the rotation, so here's your path to safety.